Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain. - Pasini,A.; Geneste,O.; Legrand,P.; Schlumberger,M.; Rossel,M.; Fournier,L.; Rudkin,B.B.; Schuffenecker,I.; Lenoir,G.M.; Billaud,M. (Oncogene, 1997)